{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:40:49Z","timestamp":1793194849904,"version":"4.5.0"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi231590-4\"><jats:title>Importance<\/jats:title><jats:p>The risks and benefits of thromboprophylaxis therapy after cancer surgery are debated. Studies that determine thrombosis risk after cancer surgery with high accuracy are needed.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231590-5\"><jats:title>Objectives<\/jats:title><jats:p>To evaluate 1-year risk of venous thromboembolic events after major cancer surgery and how these events vary over time.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231590-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This register-based retrospective observational matched cohort study included data on the full population of Sweden between 1998 and 2016. All patients who underwent major surgery for cancer of the bladder, breast, colon or rectum, gynecologic organs, kidney and upper urothelial tract, lung, prostate, or gastroesophageal tract were matched in a 1:10 ratio with cancer-free members of the general population on year of birth, sex, and county of residence. Data were analyzed from February 13 to December 5, 2023.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231590-7\"><jats:title>Exposure<\/jats:title><jats:p>Major surgery for cancer.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231590-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The main outcome was incidence of venous thromboembolic events within 1 year after the surgery. Crude absolute risks and risk differences of events within 1 year and adjusted time-dependent cause-specific hazard ratios (HRs) of postdischarge events were calculated.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231590-9\"><jats:title>Results<\/jats:title><jats:p>A total of 432\u202f218 patients with cancer (median age, 67 years [IQR, 58-75 years]; 68.7% women) and 4\u202f009\u202f343 cancer-free comparators (median age, 66 years [IQR, 57-74 years]; 69.3% women) were included in the study. The crude 1-year cumulative risk of pulmonary embolism was higher among the cancer surgery population for all cancers, with the following absolute risk differences: for bladder cancer, 2.69 percentage points (95% CI, 2.33-3.05 percentage points); for breast cancer, 0.59 percentage points (95% CI 0.55-0.63 percentage points); for colorectal cancer, 1.57 percentage points (95% CI, 1.50-1.65 percentage points); for gynecologic organ cancer, 1.32 percentage points (95% CI, 1.22-1.41 percentage points); for kidney and upper urinary tract cancer, 1.38 percentage points (95% CI, 1.21-1.55 percentage points); for lung cancer, 2.61 percentage points (95% CI, 2.34-2.89 percentage points); for gastroesophageal cancer, 2.13 percentage points (95% CI, 1.89-2.38 percentage points); and for prostate cancer, 0.57 percentage points (95% CI, 0.49-0.66 percentage points). The cause-specific HR of pulmonary embolism comparing patients who underwent cancer surgery with matched comparators peaked just after discharge and generally plateaued 60 to 90 days later. At 30 days after surgery, the HR was 10 to 30 times higher than in the comparison cohort for all cancers except breast cancer (colorectal cancer: HR, 9.18 [95% CI, 8.03-10.50]; lung cancer: HR, 25.66 [95% CI, 17.41-37.84]; breast cancer: HR, 5.18 [95% CI, 4.45-6.05]). The hazards subsided but never reached the level of the comparison cohort except for prostate cancer. Similar results were observed for deep vein thrombosis.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231590-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This cohort study found an increased rate of venous thromboembolism associated with cancer surgery. The risk persisted for about 2 to 4 months postoperatively but varied between cancer types. The increased rate is likely explained by the underlying cancer disease and adjuvant treatments. The results highlight the need for individualized venous thromboembolism risk evaluation and prophylaxis regimens for patients undergoing different surgery for different cancers.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.54352","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T16:30:50Z","timestamp":1706891450000},"page":"e2354352","source":"Crossref","is-referenced-by-count":52,"title":["Risk of Venous Thromboembolic Events After Surgery for Cancer"],"prefix":"10.1001","volume":"7","author":[{"given":"Johan","family":"Bj\u00f6rklund","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhana","family":"Rautiola","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Zelic","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustaf","family":"Edgren","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Division, Department of Medicine, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Cardiology, S\u00f6dersjukhuset, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bottai","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Henrik","family":"Vincent","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Fredholm","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Falconer","sequence":"additional","affiliation":[{"name":"Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden"},{"name":"Department of Women\u2019s and Children\u2019s Health, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Sj\u00f6vall","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per J.","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wiklund","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden"},{"name":"Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Aly","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Akre","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,2,2]]},"reference":[{"issue":"4","key":"zoi231590r1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0002-9610(70)80023-X","article-title":"Deep vein thrombosis of the leg: is there a \u201chigh risk\u201d group?","volume":"120","author":"Kakkar","year":"1970","journal-title":"Am J Surg"},{"issue":"3","key":"zoi231590r2","first-page":"446","article-title":"Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures.","volume":"90","author":"White","year":"2003","journal-title":"Thromb Haemost"},{"issue":"4","key":"zoi231590r3","first-page":"867","article-title":"Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients: the MC-4 cancer substudy.","volume":"94","author":"Kakkar","year":"2005","journal-title":"Thromb Haemost"},{"issue":"1","key":"zoi231590r4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/01.sla.0000193959.44677.48","article-title":"A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project.","volume":"243","author":"Agnelli","year":"2006","journal-title":"Ann Surg"},{"issue":"5","key":"zoi231590r5","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update.","volume":"38","author":"Key","year":"2020","journal-title":"J Clin Oncol"},{"issue":"13","key":"zoi231590r6","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa012385","article-title":"Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.","volume":"346","author":"Bergqvist","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi231590r7","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1245\/s10434-016-5127-1","article-title":"Role of extended thromboprophylaxis after abdominal and pelvic surgery in cancer patients: a systematic review and meta-analysis.","volume":"23","author":"Fagarasanu","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"zoi231590r8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/2046-4053-3-150","article-title":"Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology.","volume":"3","author":"Tikkinen","year":"2014","journal-title":"Syst Rev"},{"issue":"3","key":"zoi231590r10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0305-7372(02)00043-9","article-title":"Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis.","volume":"28","author":"Rasmussen","year":"2002","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"zoi231590r11","doi-asserted-by":"publisher","first-page":"457.e1","DOI":"10.1016\/j.urolonc.2017.01.015","article-title":"Current guidelines do not sufficiently discriminate venous thromboembolism risk in urology.","volume":"35","author":"McAlpine","year":"2017","journal-title":"Urol Oncol"},{"issue":"6","key":"zoi231590r12","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/bju.v124.6","article-title":"The role of extended venous thromboembolism prophylaxis for major urological cancer operations.","volume":"124","author":"Naik","year":"2019","journal-title":"BJU Int"},{"key":"zoi231590r13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish National Inpatient Register.","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"issue":"15","key":"zoi231590r21","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1002\/sim.v21:15","article-title":"Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.","volume":"21","author":"Royston","year":"2002","journal-title":"Stat Med"},{"issue":"3","key":"zoi231590r22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals.","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"issue":"27","key":"zoi231590r23","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1002\/sim.v32.27","article-title":"Ignoring the matching variables in cohort studies\u2014when is it valid and why?","volume":"32","author":"Sj\u00f6lander","year":"2013","journal-title":"Stat Med"},{"issue":"4","key":"zoi231590r24","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1001\/jamasurg.2021.7126","article-title":"Readmissions from venous thromboembolism after complex cancer surgery.","volume":"157","author":"Mallick","year":"2022","journal-title":"JAMA Surg"},{"key":"zoi231590r25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.suronc.2020.09.013","article-title":"Readmission with venous thromboembolism after surgical treatment by primary cancer site.","volume":"35","author":"Jarvis","year":"2020","journal-title":"Surg Oncol"},{"issue":"5","key":"zoi231590r26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/bjs\/znad035","article-title":"Timing of symptomatic venous thromboembolism after surgery: meta-analysis.","volume":"110","author":"Singh","year":"2023","journal-title":"Br J Surg"},{"issue":"2","key":"zoi231590r27","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.eururo.2012.09.041","article-title":"Thromboembolic events following surgery for prostate cancer.","volume":"63","author":"Van Hemelrijck","year":"2013","journal-title":"Eur Urol"},{"issue":"1","key":"zoi231590r28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.juro.2014.08.091","article-title":"Thromboembolic complications in 3,544 patients undergoing radical prostatectomy with or without lymph node dissection.","volume":"193","author":"Tyritzis","year":"2015","journal-title":"J Urol"},{"issue":"12","key":"zoi231590r29","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1634\/theoncologist.2013-0226","article-title":"Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis.","volume":"18","author":"Lyman","year":"2013","journal-title":"Oncologist"},{"issue":"14","key":"zoi231590r30","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study.","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"issue":"5","key":"zoi231590r31","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3390\/cancers13051033","article-title":"Association between radiotherapy and risk of cancer associated venous thromboembolism: a sub-analysis of the COMPASS-CAT Study.","volume":"13","author":"Temraz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"zoi231590r16","volume-title":"Health Classifications in the Nordic Countries: Historic Development in a National and International Perspective","author":"Smedby","year":"2006"},{"key":"zoi231590r20","volume-title":"Data Analysis With Competing Risks and Intermediate States","author":"Geskus","year":"2016"},{"key":"zoi231590r9","unstructured":"European Association of Urology. Guidelines. Accessed October 3, 2022. https:\/\/uroweb.org\/guidelines"},{"key":"zoi231590r14","unstructured":"Socialstyrelsen. National Patient Register. Updated January 14, 2022. Accessed December 20, 2022. https:\/\/www.socialstyrelsen.se\/en\/statistics-and-data\/registers\/national-patient-register\/"},{"key":"zoi231590r15","unstructured":"Socialstyrelsen. Klassifikation av operationer: sj\u00e4tte upplagan. 1988. Accessed December 20, 2022. https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/dokument-webb\/klassifikationer-och-koder\/klassifikation-av-operationer-sjatte-upplagan.pdf"},{"key":"zoi231590r17","unstructured":"Socialstyrelsen. The Swedish Cause of Death Register. Updated October 18, 2019. Accessed December 2, 2022. https:\/\/www.socialstyrelsen.se\/statistik-och-data\/register\/dodsorsaksregistret\/"},{"key":"zoi231590r18","unstructured":"StatisticsSweden. Description of the register: Total Population Register. Updated June 19, 2017. Accessed December 2, 2022. https:\/\/www.scb.se\/contentassets\/8f66bcf5abc34d0b98afa4fcbfc0e060\/rtb-bar-2016-eng.pdf"},{"key":"zoi231590r19","unstructured":"Socialstyrelsen. National Cancer Register. Updated January 14, 2022. Accessed December 20, 2022. https:\/\/www.socialstyrelsen.se\/en\/statistics-and-data\/registers\/national-cancer-register\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2814634\/bjrklund_2024_oi_231590_1706545195.04844.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T16:30:58Z","timestamp":1706891458000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2814634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.54352","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,2]]}}}